Natriumbikarbonat ”sad” (Sodium Hydrogen Carbonate)

Sodium bicarbonate, the active ingredient in Natriumbikarbonat “sad”, is a buffering agent presented as an intravenous solution for systemic pH management in acute care settings. It helps correct metabolic acidosis and supports electrolyte balance during emergency interventions. It is commonly used in emergency departments, operating rooms and dialysis units where rapid correction of acid–base imbalance is required.

GNH USA supplies Natriumbikarbonat “sad” as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and intensive‑care units worldwide, ensuring quality‑assured batches that meet EU regulatory standards.

Sodium bicarbonate is administered intravenously to address acid–base disturbances and related clinical conditions. - Metabolic acidosis: restores normal systemic pH by buffering excess hydrogen ions. - Cardiac arrest (ACLS): improves myocardial contractility and counteracts acidemia during resuscitation. - Hyperkalemia: promotes intracellular shift of potassium, aiding in temporary reduction of serum potassium levels. - Certain drug overdoses (e.g., tricyclic antidepressants): alkalinizes urine to enhance drug elimination.

Intravenous sodium bicarbonate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Metabolic alkalosis: excessive rise in blood pH. - Fluid overload: increased intravascular volume. - Hypokalemia: lowered serum potassium. - Increased CO₂ production: may exacerbate respiratory distress. - Local IV site irritation: pain or phlebitis at infusion site.

Serious or Rare Side Effects: - Severe alkalosis: can lead to seizures or cardiac arrhythmias. - Pulmonary edema: accumulation of fluid in lungs. - Paradoxical intracellular acidosis: worsening cellular acidosis despite systemic correction. - Anaphylactic reaction: rare hypersensitivity with airway compromise. - Severe hypernatremia: neurological symptoms such as confusion or coma.

Safe administration of sodium bicarbonate requires careful assessment and monitoring. - Assess acid–base status: confirm metabolic acidosis before infusion. - Monitor electrolytes: check serum sodium, potassium and bicarbonate levels regularly. - Adjust infusion rate: titrate based on pH response and patient tolerance. - Use caution in renal impairment: reduced excretion may increase risk of alkalosis. - Avoid in severe pre‑existing alkalosis: may exacerbate condition. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium bicarbonate can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Concomitant alkalinizing agents (e.g., calcium carbonate): may cause severe systemic alkalosis. - Acid‑dependent drugs (e.g., aspirin, certain antifungals): reduced absorption and efficacy. - Loop diuretics: enhanced electrolyte disturbances, especially hypokalemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor potassium and renal function. - Digoxin: risk of toxicity with altered potassium levels. - NSAIDs: may increase risk of fluid overload and renal impairment.